T1	duration 324 341	From 1992 to 1997
T2	No-of-participants 343 349	13,388
T3	eligibility 350 457	women with estimated 5-year breast cancer risk greater than 1.66% or a history of lobular carcinoma in situ
T4	intervention 530 539	tamoxifen
T5	control 547 554	placebo
T6	outcome-Measure 681 707	baseline cigarette smoking
T7	outcome-Measure 709 739	leisure-time physical activity
T8	outcome-Measure 741 760	alcohol consumption
T9	outcome 853 917	breast cancer, lung cancer, colon cancer, and endometrial cancer
T10	outcome 972 993	risk of breast cancer
T11	outcome 1066 1077	lung cancer
T12	outcome 1147 1159	colon cancer
T13	outcome 1252 1270	breast cancer risk
T14	outcome 1419 1437	endometrial cancer
T15	outcome 1541 1561	risk of colon cancer
